Angptl2-deficient mice showed reduced AAA progression compared with wild-type mice; in particular, Angptl2-deficient mice exhibited smaller aneurysms, less vascular structural destruction, and lower MMP expression levels (53). Here, ANGPTL2 is linked to triple-A syndrome.